Hudson Valley Hematology Oncology Associates (Site 236) — Hawthorne, New York

Hudson Valley Hematology Oncology Associates (Site 236) is a clinical research site located in Hawthorne, New York, United States 10532.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Hudson Valley Hematology Oncology Associates (Site 236) has participated in 1 clinical trials.

Therapeutic areas: Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hudson Valley Hematology Oncology Associates (Site 236)?

Hudson Valley Hematology Oncology Associates (Site 236) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hudson Valley Hematology Oncology Associates (Site 236) conducted?

Hudson Valley Hematology Oncology Associates (Site 236) has 1 clinical trials on record. Their work covers Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL.

Is Hudson Valley Hematology Oncology Associates (Site 236) accredited by Crixeo Health?

Hudson Valley Hematology Oncology Associates (Site 236) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hudson Valley Hematology Oncology Associates (Site 236)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.